RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE

被引:41
|
作者
Stone, Rivka C. [1 ,2 ]
Du, Peicheng [3 ]
Feng, Di [1 ,2 ]
Dhawan, Kopal [4 ]
Ronnblom, Lars [5 ]
Eloranta, Maija-Leena [5 ]
Donnelly, Robert [4 ]
Barnes, Betsy J. [1 ,2 ]
机构
[1] UMDNJ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA
[2] UMDNJ, Univ Hosp Canc Ctr, New Jersey Med Sch, Newark, NJ USA
[3] UMDNJ, Dept Informat Syst & Technol, Newark, NJ USA
[4] UMDNJ, New Jersey Med Sch, Mol Resource Facil, Newark, NJ USA
[5] Uppsala Univ, Rheumatol Sect, Dept Med Sci, Uppsala, Sweden
来源
PLOS ONE | 2013年 / 8卷 / 01期
基金
瑞典研究理事会;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON REGULATORY FACTOR; GREEN FLUORESCENT PROTEIN; GENETIC-VARIANTS; RISK HAPLOTYPE; DISEASE; ACTIVATION; ALPHA; ASSOCIATION; INTERFERON-REGULATORY-FACTOR-5;
D O I
10.1371/journal.pone.0054487
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Polymorphisms in the interferon regulatory factor 5 (IRF5) gene have been consistently replicated and shown to confer risk for or protection from the development of systemic lupus erythematosus (SLE). IRF5 expression is significantly upregulated in SLE patients and upregulation associates with IRF5-SLE risk haplotypes. IRF5 alternative splicing has also been shown to be elevated in SLE patients. Given that human IRF5 exists as multiple alternatively spliced transcripts with distinct function(s), it is important to determine whether the IRF5 transcript profile expressed in healthy donor immune cells is different from that expressed in SLE patients. Moreover, it is not currently known whether an IRF5-SLE risk haplotype defines the profile of IRF5 transcripts expressed. Using standard molecular cloning techniques, we identified and isolated 14 new differentially spliced IRF5 transcript variants from purified monocytes of healthy donors and SLE patients to generate an IRF5 variant transcriptome. Next-generation sequencing was then used to perform in-depth and quantitative analysis of full-length IRF5 transcript expression in primary immune cells of SLE patients and healthy donors by next-generation sequencing. Evidence for additional alternatively spliced transcripts was obtained from de novo junction discovery. Data from these studies support the overall complexity of IRF5 alternative splicing in SLE. Results from next-generation sequencing correlated with cloning and gave similar abundance rankings in SLE patients thus supporting the use of this new technology for in-depth single gene transcript profiling. Results from this study provide the first proof that 1) SLE patients express an IRF5 transcript signature that is distinct from healthy donors, 2) an IRF5-SLE risk haplotype defines the top four most abundant IRF5 transcripts expressed in SLE patients, and 3) an IRF5 transcript signature enables clustering of SLE patients with the H2 risk haplotype.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
    Cole Trapnell
    Adam Roberts
    Loyal Goff
    Geo Pertea
    Daehwan Kim
    David R Kelley
    Harold Pimentel
    Steven L Salzberg
    John L Rinn
    Lior Pachter
    Nature Protocols, 2012, 7 : 562 - 578
  • [2] Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
    Trapnell, Cole
    Roberts, Adam
    Goff, Loyal
    Pertea, Geo
    Kim, Daehwan
    Kelley, David R.
    Pimentel, Harold
    Salzberg, Steven L.
    Rinn, John L.
    Pachter, Lior
    NATURE PROTOCOLS, 2012, 7 (03) : 562 - 578
  • [3] Polyester: simulating RNA-seq datasets with differential transcript expression
    Frazee, Alyssa C.
    Jaffe, Andrew E.
    Langmead, Ben
    Leek, Jeffrey T.
    BIOINFORMATICS, 2015, 31 (17) : 2778 - 2784
  • [4] Transcript quantification with RNA-Seq data
    Bohnert, Regina
    Behr, Jonas
    Raetsch, Gunnar
    BMC BIOINFORMATICS, 2009, 10 : P5
  • [5] Transcript quantification with RNA-Seq data
    Regina Bohnert
    Jonas Behr
    Gunnar Rätsch
    BMC Bioinformatics, 10
  • [6] IRF5 expression profiling in SLE patients: new leads to a pathogenic signature?
    BJ Barnes
    RC Stone
    P Du
    D Feng
    Arthritis Research & Therapy, 14 (Suppl 3):
  • [7] Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown
    Pertea, Mihaela
    Kim, Daehwan
    Pertea, Geo M.
    Leek, Jeffrey T.
    Salzberg, Steven L.
    NATURE PROTOCOLS, 2016, 11 (09) : 1650 - 1667
  • [8] Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown
    Mihaela Pertea
    Daehwan Kim
    Geo M Pertea
    Jeffrey T Leek
    Steven L Salzberg
    Nature Protocols, 2016, 11 : 1650 - 1667
  • [9] IRF5 expression profiling in SLE patients: new leads to a pathogenic signature?
    Barnes, B. J.
    Stone, R. C.
    Du, P.
    Feng, D.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14
  • [10] IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE
    Li, Dan
    Matta, Bharati
    Song, Su
    Nelson, Victoria
    Diggins, Kirsten
    Simpfendorfer, Kim R.
    Gregersen, Peter K.
    Linsley, Peter
    Barnes, Betsy J.
    JCI INSIGHT, 2020, 5 (02)